Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1993
10/28/1993WO1993021218A1 Synthetic polypeptides derived from the hiv envelope glycoprotein
10/28/1993WO1993021217A1 Invertebrate peptides
10/28/1993WO1993021206A1 Synthetic, stabilized, three-dimension polypeptides
10/28/1993WO1993021145A1 Non-steroid progesterone receptor agonist and antagonist compounds and methods
10/28/1993WO1993020935A1 Activated substrate materials, their production and use
10/28/1993WO1993020856A1 Polyamino acid superabsorbents
10/28/1993WO1993020852A2 Macrocyclic chelating agents, chelates and conjugates thereof
10/28/1993WO1993020849A1 Low toxicity interleukin-2 analogues for use in immunotherapy
10/28/1993WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993WO1993020846A1 Recombinant influenza vaccines
10/28/1993WO1993020844A1 Papillomavirus e7 protein
10/28/1993WO1993020842A1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides
10/28/1993WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993WO1993020840A1 Induction of ctl responses
10/28/1993WO1993020836A1 Treating disorders by application of insulin-like growth factors and analogs
10/28/1993WO1993020834A1 Methods and compositions for oral delivery of therapeutic agents
10/28/1993WO1993020691A1 Method for inducing tumor immunity
10/28/1993WO1993019089A3 Oxygen carrier
10/28/1993WO1993018148A3 Tumor necrosis factor with modified channel activity
10/28/1993WO1993017115A3 Dysentery vaccine stimulating an immune response against shigatoxin, plasmids and host strains for it
10/28/1993WO1993016719A3 Use of platelet derived growth factor in ophthalmic wound healing
10/28/1993WO1993014206A3 Synthetic peptides for a rubella vaccine
10/28/1993WO1993013196A3 Method for increasing recombinant protein production
10/28/1993WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993CA2388198A1 Adrenocorticotropic hormone receptor and uses
10/28/1993CA2134115A1 Method for purifying an aqueous solution of raw albumin
10/28/1993CA2133999A1 Recombinant mutants for inducing specific immune responses
10/28/1993CA2133749A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
10/28/1993CA2133739A1 Immunotoxins directed against c-erbb-2 (her-2/neu) related surface antigens
10/28/1993CA2133339A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993CA2133325A1 Non-steroid progesterone receptor agonist and antagonist compounds and methods
10/28/1993CA2133090A1 Endothelin antagonists ii
10/28/1993CA2132527A1 Polyamino acid superabsorbents
10/28/1993CA2131166A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993CA2118502A1 Supression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides
10/28/1993CA2118234A1 Genetically engineered attenuated viruses
10/28/1993CA2118123A1 Method for inducing tumor immunity
10/28/1993CA2118033A1 Synthetic polypeptides derived from the hiv envelope gylcoprotein
10/28/1993CA2118028A1 Ultrapure human epidermal growth factor
10/28/1993CA2118026A1 Induction of ctl responses
10/28/1993CA2117887A1 Polysaccharide binding fusion proteins and conjugates
10/28/1993CA2117780A1 Cartillage matrix protein and methods for use
10/28/1993CA2117779A1 T cell epitopes of the major allergens from ambrosia artemisifolia
10/28/1993CA2117775A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
10/28/1993CA2117756A1 Oligonucleotide sequences and transgenic animals transfected therewith having reduced sensitivity to narcotic analgesics
10/28/1993CA2117747A1 A novel hyaluronan receptor protein and novel hyaluronan binding peptides
10/28/1993CA2110911A1 Treating disorders by application of insulin-like growth factors and analogs
10/27/1993EP0567448A1 Factor VIII preparation
10/27/1993EP0567100A1 Mutant respiratory syncytial virus (RSV) vaccines containing same and methods of use
10/27/1993EP0567088A2 Processes for the preparation of amylase inhibitor
10/27/1993EP0566877A2 Enzymatic hydrolysis of proteines
10/27/1993EP0566824A1 Enzymatic peptide synthesis
10/27/1993EP0566732A1 Adeno-associated virus-2 basal vectors
10/27/1993EP0566673A1 Biosynthetic pdgf antagonists
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993EP0566630A1 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli
10/27/1993EP0566611A1 Analogs of piscine lhrh
10/27/1993EP0566596A1 Increased expression by a second transferred sequence in transgenic organisms
10/27/1993EP0566579A1 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions
10/27/1993EP0394349B1 Wound healing
10/26/1993US5256770 Oxidation resistant thrombomodulin analogs
10/26/1993US5256769 Separating protein or its N-methionine analog from mixture utilizing difference in isoelectric points
10/26/1993US5256768 Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics
10/26/1993US5256767 Retroviral antigens
10/26/1993US5256766 Recombinant thrombin receptor and related pharmaceuticals
10/26/1993US5256651 Hydrophilic-hydrophobic derivatives of polygalactomannans containing tertiary amine functionality
10/26/1993US5256643 For diagnosis of colorectal and breast cancers
10/26/1993US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
10/26/1993US5256641 Covalent polar lipid-peptide conjugates for immunological targeting
10/26/1993US5256568 Antibiotic resistance
10/26/1993US5256561 Monoclonal antibody to HIV-2 and uses thereof
10/26/1993US5256560 Suspension of mammalian, non-murine, non-human cells comprised of pluripotent lymphohematopoietic non-adherent progenitor stem cells which produce primitive cell colony stimulating factors
10/26/1993US5256559 Storing the platelets in a solution of synthetic hirudin peptides antiagglomerants
10/26/1993US5256554 Expression of human immunodeficiency virus (HIV) reverse transcriptase
10/26/1993US5256546 Plasmid which upon introduction into bacterial host renders host capable of effecting expression of growth hormone
10/26/1993US5256534 CD4+, latently HIV-1-infected hematopoietic progenitor cells
10/26/1993US5256439 Extracting the fruits with aqueous solution, deactivating the proteases by heat pasteurization
10/26/1993US5256411 Immune cell proliferation inhibitors
10/26/1993US5255518 Reversible mechanochemical engines comprised of bioelastomers capable of modulable inverse temperature transitions for the interconversion of chemical and mechanical work
10/26/1993CA1323728C Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
10/26/1993CA1323727C Glutamine-containing peptides, a process for the preparation thereof, and the use thereof
10/26/1993CA1323567C Method for purification of antibodies
10/25/1993CA2094797A1 Method of treating and preventing viral infections using hbnf and mk protein
10/21/1993CA2093735A1 Amyloid precursor-like protein and uses thereof
10/20/1993EP0566554A2 Production of recombinant proteins using herpes virus promoters and VP16 transactivators
10/20/1993EP0566525A2 Recombinant tospovirus DNA constructs and plants comprising such constructs
10/20/1993EP0566410A2 Derivatives of adipogenesis inhibitory factor, their preparation and their use
10/20/1993EP0566289A1 Analysis of hemoglobin variants by capillary electrophoresis
10/20/1993EP0566237A2 Retroviral protease inhibitors
10/20/1993EP0566158A1 The use of alpha-1-antitrypsin mutants in the manufacture of medicaments, and therapeutic formulations using mutants and their preparation
10/20/1993EP0566157A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension
10/20/1993EP0566066A1 Antigens of human non-small lung carcinoma
10/20/1993EP0565978A1 Artivated carriers, their fabrication and use
10/20/1993EP0565794A1 Induction of CTL responses
10/20/1993EP0565704A1 Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
10/20/1993EP0565665A1 Preparation of prothrombin time reagents from recombinant human tissue factor and synthetic phospholipids
10/20/1993EP0565638A1 Tumor susceptible non-human animals
10/20/1993EP0565626A1 Fusions of a viral protein and a destructive enzyme
10/20/1993EP0565607A1 Protection group, compoud protected by this group and device for grafting the protection group onto the compound being protected
10/20/1993EP0565590A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
1 ... 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 ... 2916